Alan G. D. Hoffman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alan G. D. Hoffman has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
A. Kuksis
5 shared publicationsArnis Kuksis
3 shared publicationsJ.J. Myher
2 shared publicationsR. G. H. Downer
Department of Biology University of Waterloo Waterloo Ontario N2L 3G1 Canada
2 shared publicationsR.G.H. Downer
2 shared publicationsA. Suffredini
National Institutes of Health
1 shared publication
Latest Publications
- 1 February 1994
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 169 (2) , 356-368
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
A model of primary pulmonary aspergillosis in rabbits was developed to reproduce the persistent levels of profound granulocytopenia and the histopathologic features of bronchopneumonia, vascular invasion, and hemorrhagic infarction encountered in humans. d-mannitol was detectable in bronchoalveolar lavage fluid by gas-liquid chromatography/mass spectroscopy, and galactomannan was measurable in serum by latex agglutination immunoassay. A pharmacokinetically distinctive unilamellar vesicle formulation of liposomal amphotericin B, 5 mg/kg/day intravenously, compared with high-dose conventional desoxycholate amphotericin B, 1 mg/kg/ day intravenously, was more effective in preventing nephrotoxicity, increasing survival, reducing the number of viable organisms, and decreasing tissue injury due to Aspergillus organisms. Thus, d-mannitol in lavage fluid and galactomannan in serum may be useful markers of pulmonary aspergillosis, and liposomal amphotericin B was significantly more effective and safer than desoxycholate amphotericin B for treatment of pulmonary aspergillosis in profoundly granulocytopenic rabbits.
- 1 February 1994
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 169 (2) , 356-368
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
A model of primary pulmonary aspergillosis in rabbits was developed to reproduce the persistent levels of profound granulocytopenia and the histopathologic features of bronchopneumonia, vascular invasion, and hemorrhagic infarction encountered in humans. d-mannitol was detectable in bronchoalveolar lavage fluid by gas-liquid chromatography/mass spectroscopy, and galactomannan was measurable in serum by latex agglutination immunoassay. A pharmacokinetically distinctive unilamellar vesicle formulation of liposomal amphotericin B, 5 mg/kg/day intravenously, compared with high-dose conventional desoxycholate amphotericin B, 1 mg/kg/ day intravenously, was more effective in preventing nephrotoxicity, increasing survival, reducing the number of viable organisms, and decreasing tissue injury due to Aspergillus organisms. Thus, d-mannitol in lavage fluid and galactomannan in serum may be useful markers of pulmonary aspergillosis, and liposomal amphotericin B was significantly more effective and safer than desoxycholate amphotericin B for treatment of pulmonary aspergillosis in profoundly granulocytopenic rabbits.
- 1 October 1992
- Published by Springer Nature in Inflammation
- Vol. 16 (5) , 561-570
Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin
Phospholipase A2 (PLA2) activity was measured in the serum of 23 individuals infused intravenously with endotoxin (EN) at a dose of 4 ng/kg body weight. A marked increase in PLA2 was noted 3 h after EN challenge (mean 828 ± 513 units/ml), reached its maximum at 24 h after the challenge (mean 2667 ± 2442 units/ ml), and was still evident at 48 h (mean 763 ± 366 units/ml). In contrast, TNF levels were maximal (mean 712 ± 375 pg/ml) 90 min after the EN challenge and subsided to very low values (5 ± 5 pg/ml) 5 h after the challenge. There was a positive correlation between the maximum response of TNF and that of PLA2 (r = 0.82,P < 0.01). Administration of ibuprofen or pentoxifylline did not alter the PLA2 response. EN challenge did not affect serum pancreatic PLA2 concentration or that of the lysosomal cationic enzyme, lysozyme. Neutralizing antibody against human recombinant (synovial type) PLA2 completely abolished PLA2 activity in the sera tested. We conclude that EN infusions cause marked intravascular release of nonpancreatic secretory PLA2 and that the magnitude of this response seems to be related to the prior generation of TNF.
- 1 October 1992
- Published by Springer Nature in Inflammation
- Vol. 16 (5) , 561-570
Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin
Phospholipase A2 (PLA2) activity was measured in the serum of 23 individuals infused intravenously with endotoxin (EN) at a dose of 4 ng/kg body weight. A marked increase in PLA2 was noted 3 h after EN challenge (mean 828 ± 513 units/ml), reached its maximum at 24 h after the challenge (mean 2667 ± 2442 units/ ml), and was still evident at 48 h (mean 763 ± 366 units/ml). In contrast, TNF levels were maximal (mean 712 ± 375 pg/ml) 90 min after the EN challenge and subsided to very low values (5 ± 5 pg/ml) 5 h after the challenge. There was a positive correlation between the maximum response of TNF and that of PLA2 (r = 0.82,P < 0.01). Administration of ibuprofen or pentoxifylline did not alter the PLA2 response. EN challenge did not affect serum pancreatic PLA2 concentration or that of the lysosomal cationic enzyme, lysozyme. Neutralizing antibody against human recombinant (synovial type) PLA2 completely abolished PLA2 activity in the sera tested. We conclude that EN infusions cause marked intravascular release of nonpancreatic secretory PLA2 and that the magnitude of this response seems to be related to the prior generation of TNF.
- 1 July 1991
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 5 (1) , 71-79
Use of a Monoclonal Antibody Enzyme-linked Immunosorbent Assay to Measure Human Respiratory Glycoprotein Production In Vitro
High-molecular-weight glycoprotein from human airway cultures was used to generate murine monoclonal antibodies, one of which recognizes a high-molecular-weight, hyaluronidase-resistant glycoprotein localized by immunofluorescent microscopy and immunogold electron microscopy to the secretory granules of human airway submucosal gland mucous cells and goblet cells. This monoclonal antibody was used to develop an enzyme-linked immunosorbent assay (ELISA) that was adapted to the study of respiratory glycoprotein secretion from human airways in vitro. Using the assay, the effect of a known mucus secretagogue, the cholinergic agonist methacholine, was studied on explant cultures of tissue from human bronchus or from human nasal mucosa. In studies of human bronchus explants, methacholine, 100 and 10 µM, stimulated increased secretion of respiratory glycoprotein (RGP) by 109 ± 8% (n = 14; P < 0.001) and 96 ± 14% (n = 9; P < 0.001), respectively, above control values. In studies of human nasal turbinate mucosal explants, methacholine, 100 and 10 µM, stimulated increased secretion of RGP by 75 ± 28% (n = 7; P < 0.01) and 70 ± 21% (n = 4; P < 0.01) above control values. An ELISA for the measurement of RGP secretion may provide a sensitive and more specific method for the performance of in vitro studies of RGP secretion from human tissues.
- 1 July 1991
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 5 (1) , 71-79
Use of a Monoclonal Antibody Enzyme-linked Immunosorbent Assay to Measure Human Respiratory Glycoprotein Production In Vitro
High-molecular-weight glycoprotein from human airway cultures was used to generate murine monoclonal antibodies, one of which recognizes a high-molecular-weight, hyaluronidase-resistant glycoprotein localized by immunofluorescent microscopy and immunogold electron microscopy to the secretory granules of human airway submucosal gland mucous cells and goblet cells. This monoclonal antibody was used to develop an enzyme-linked immunosorbent assay (ELISA) that was adapted to the study of respiratory glycoprotein secretion from human airways in vitro. Using the assay, the effect of a known mucus secretagogue, the cholinergic agonist methacholine, was studied on explant cultures of tissue from human bronchus or from human nasal mucosa. In studies of human bronchus explants, methacholine, 100 and 10 µM, stimulated increased secretion of respiratory glycoprotein (RGP) by 109 ± 8% (n = 14; P < 0.001) and 96 ± 14% (n = 9; P < 0.001), respectively, above control values. In studies of human nasal turbinate mucosal explants, methacholine, 100 and 10 µM, stimulated increased secretion of RGP by 75 ± 28% (n = 7; P < 0.01) and 70 ± 21% (n = 4; P < 0.01) above control values. An ELISA for the measurement of RGP secretion may provide a sensitive and more specific method for the performance of in vitro studies of RGP secretion from human tissues.
- 1 March 1984
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 792 (3) , 254-269
An examination of the stereochemical course of acylation of 2-monoacylglycerols by rat intestinal villus cells using [2H3]palmitic acid
- 1 March 1984
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 792 (3) , 254-269
An examination of the stereochemical course of acylation of 2-monoacylglycerols by rat intestinal villus cells using [2H3]palmitic acid
- 1 January 1982
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 710 (1) , 53-62
Relative acylglycerol acyltransferase activities in homogenates of enzymically dispersed rat jejunal villus and crypt cells
- 1 January 1982
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 710 (1) , 53-62
Relative acylglycerol acyltransferase activities in homogenates of enzymically dispersed rat jejunal villus and crypt cells
- 1 August 1981
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 665 (2) , 283-298
Synthesis and release of lipids and lipoproteins by isolated rat jejunal enterocytes in the presence of sodium taurocholate
- 1 August 1981
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 665 (2) , 283-298
Synthesis and release of lipids and lipoproteins by isolated rat jejunal enterocytes in the presence of sodium taurocholate
- 1 February 1980
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 36 (2) , 202-204
Culture of presumptive epithelial cells from jejunal mucosa of axenic rats
- 1 February 1980
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 36 (2) , 202-204
Culture of presumptive epithelial cells from jejunal mucosa of axenic rats
- 1 December 1979
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 57 (12) , 1393-1400
In vitro response of enzyme-dispersed rat intestinal villus and crypt cells to hormones
Villus and crypt cells isolated from rat jejunal tissue by an improved enzymatic procedure were tested for their ability to respond to hormonal stimulation using several metabolic tracers. Incubation with cyclic AMP, theophylline, isoproterenol, and epinephrine resulted in 20–70% increases in incorporation of D-glucosamine into glycoproteins. The newly formed material was largely (90–95%) recovered from the medium, apparently as a result of active secretion, because tests for cellular leakage and breakage failed to account for it. The above hormones and pharmacological agents as well as glucagon, insulin, and Cortisol, however, failed to modify the rate of incorporation of acetate and glucose into the total cellular lipids of the isolated crypt and villus cells. Likewise, segments of intestinal tissue, although readily responding with increased incorporation of D-glucosamine (50–100%), failed to demonstrate any effect of added hormones on the incorporation of acetate even when lipogenesis was stimulated by addition of glucose or fructose. These findings are in agreement with certain previous studies with intact intestinal tissue in vivo and in vitro, and attest to the suitability of the enzyme-dispersed cells for metabolic studies.
- 1 December 1979
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 57 (12) , 1393-1400
In vitro response of enzyme-dispersed rat intestinal villus and crypt cells to hormones
Villus and crypt cells isolated from rat jejunal tissue by an improved enzymatic procedure were tested for their ability to respond to hormonal stimulation using several metabolic tracers. Incubation with cyclic AMP, theophylline, isoproterenol, and epinephrine resulted in 20–70% increases in incorporation of D-glucosamine into glycoproteins. The newly formed material was largely (90–95%) recovered from the medium, apparently as a result of active secretion, because tests for cellular leakage and breakage failed to account for it. The above hormones and pharmacological agents as well as glucagon, insulin, and Cortisol, however, failed to modify the rate of incorporation of acetate and glucose into the total cellular lipids of the isolated crypt and villus cells. Likewise, segments of intestinal tissue, although readily responding with increased incorporation of D-glucosamine (50–100%), failed to demonstrate any effect of added hormones on the incorporation of acetate even when lipogenesis was stimulated by addition of glucose or fructose. These findings are in agreement with certain previous studies with intact intestinal tissue in vivo and in vitro, and attest to the suitability of the enzyme-dispersed cells for metabolic studies.
End product specificity of triacylglycerol lipases from intestine, fat body, muscle and haemolymph of the American cockroach,Periplaneta americana L.
The triacylglycerol‐hydrolyzing capacity of tissue homogenates has been investigated for midgut, fat body, thoracic musculature and haemolymph of the American cockroach,Periplaneta americana. The greatest lipolytic activity was demonstrated in midgut homogenates with decreasing levels of activity present in fat body, muscle and haemolymph. Comparison of the lipolytic products resulting from triacylglycerol hydrolysis indicates that midgut homogenates effect the production ofsn‐2‐monoacylglycerols and free fatty acids, whereas the other tissues that were examined favor the accumulation of diacylglycerols. Stereospecific analysis of the diacylglycerol products of triacylglycerol hydrolysis demonstrated that the lipolytic activities of midgut and muscle homogenates result in the production of a racemic mixture of thesn‐1,2‐andsn‐2,3‐enantiomers, but the fat body and haemolymph show a preference for the accumulation of thesn‐1,2‐isomer.
End product specificity of triacylglycerol lipases from intestine, fat body, muscle and haemolymph of the American cockroach,Periplaneta americana L.
The triacylglycerol‐hydrolyzing capacity of tissue homogenates has been investigated for midgut, fat body, thoracic musculature and haemolymph of the American cockroach,Periplaneta americana. The greatest lipolytic activity was demonstrated in midgut homogenates with decreasing levels of activity present in fat body, muscle and haemolymph. Comparison of the lipolytic products resulting from triacylglycerol hydrolysis indicates that midgut homogenates effect the production ofsn‐2‐monoacylglycerols and free fatty acids, whereas the other tissues that were examined favor the accumulation of diacylglycerols. Stereospecific analysis of the diacylglycerol products of triacylglycerol hydrolysis demonstrated that the lipolytic activities of midgut and muscle homogenates result in the production of a racemic mixture of thesn‐1,2‐andsn‐2,3‐enantiomers, but the fat body and haemolymph show a preference for the accumulation of thesn‐1,2‐isomer.